A Comparative Analysis of Early Stage Diabetes Prediction using Machine Learning and Deep Learning Approach

Abstract

Diabetes is a disease that affects how your body processes blood sugar and is often referred to as diabetes mellitus. Insulin insufficiency and ineffective insulin use coincide when the pancreas cannot produce enough insulin or the human body cannot use the insulin that is produced. Insulin is a hormone produced by the pancreas that helps in the transport of glucose from food into cells for use as energy. The common effect of uncontrolled diabetes is hyper-glycemia, or high blood sugar, which plus other health concerns, raises serious health issues, majorly towards the nerves and blood vessels. According to 2014 statistics, people aged 18 or older had diabetes and, according to 2019 statistics, diabetes alone caused 1.5 million deaths. However, because of the rapid growth of machine learning(ML) and deep learning (DL) classification algorithms. indifferent sectors, like health science, it is now remarkably easy to detect diabetes in its early stages. In this experiment, we have conducted a comparative analysis of several ML and DL techniques for early diabetes disease prediction. Additionally, we used a diabetes dataset from the UCI repository that has 17 attributes, including class, and evaluated the performance of all proposed machine learning and deep learning classification algorithms using a variety of performance metrics. According to our experiments, the XGBoost classifier outperformed the rest of the algorithms by approximately 100.0%, while the rest of the algorithms were over 90.0% accurate.<br>

Early Diabetes Prediction: A Comparative Study Using Machine Learning Techniques

“…Among the six classification models, random forest showed high prediction capability in terms of accuracy, precision, recall, and F-score. Random forest model outperformed both the previously published models [6,7], had the best predictive ability to identify patients at high risk for DM, and may be used to risk stratify patients with regard to their risk of DM development.…”